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A B S T R A C T
Prostate cancer (PC) is one of the most common cancers among men. Progression of prostate cancer is
associated with an increase in cellular level of interleukin-6 (IL-6). Gallic acid (GA) is a polyhydroxy
phenolic compound which can inhibit the growth of cancer cells. The aim of this study was to evaluate
the effects of GA treatment on cell viability, proliferation, invasion, IL-6 gene expression, IL-6 secretion,
cellular levels of pSTAT3, pERK1/2, and pAKT signaling proteins in human prostate cancer PC3 cells. PC3
cells viability after treatment with GA (0–120 mM) was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. The expression of IL-6 was investigated using real-time
polymerase chain reaction. Cellular concentration of pSTAT3, pERK1/2, and pAKT signaling proteins were
determined by Western blotting technic. PC3 cells invasion was assessed by invasion assay test.
Treatment with GA caused a signiﬁcant decrease in cell viability, proliferation, invasion, cellular levels of
pSTAT3, pERK1/2, and pAKT signaling proteins after 48 h in a dose-dependent manner. The level of IL-6
and its gene expression decreased signiﬁcantly in PC3 cells treated with GA. Our results show that IL-6
down-regulation and decreased IL-6 protein level in PC3 cells by GA resulted in diminishing of pSTAT3,
pERK1/2, and pAKT signaling proteins which lead to the reduction of the cell survival, proliferation, and
invasion in PC3 cells. Therefore, it seems that GA can be considered an anticancer agent in the treatment
of prostate cancer.




Prostate cancer (PC), the most frequently diagnosed non-
cutaneous cancer, is one of the most common cancers among men
which is androgen dependent in initial stage. PC, however,
eventually progresses to be androgen-independent phenotype
[1]. Studies show that PC in the form of androgen-independent is
associated with a signiﬁcant increase in IL-6 [2]. IL-6 is a multi-
functional cytokine that plays a role in numerous physiological
processes, including growth and immune responses. It can also be
involved in many malignant tumors such as myeloma, renal cell
carcinoma, cervical carcinoma and prostatic carcinoma [3]. IL-6
not only has a key role in the transition of PC from an androgen-* Corresponding author.
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important role in prostate cancer progression through a number of
signaling pathways such as JAK-STAT, PI3k-AKT, MAPk-ERK, and
especially JAK-STAT pathway [4–6]. Therefore, investigations on IL-
6 signaling pathways can be effective in achieving new therapeutic
approaches in oncology.
Studies have shown that consumption of fruit and vegetables in
the diet can reduce the risk of different diseases especially some
cancers [7–9]. In the past decade, several researches have been done
to examthe role some antioxidants as natural anti-tumor products in
prostate cancer cell lines [10,11]. Gallic acid (GA) is a polyhydroxy
phenolic compound that is widely found in grapes vegetables and
many fruit. GA has anti-inﬂammatory, anti-virus, and free radical
scavenger activities [12]. Also, it is reported that GA can inhibit
growth of cancer cells by inducing apoptosis through the ROS-
mediated pathways in human prostate cancer cells [13]. Therefore,
the aim of this study was to investigate the effects of GA on the IL-6ord University from ClinicalKey.com by Elsevier on May 08, 2018.
. Copyright ©2018. Elsevier Inc. All rights reserved.
Fig. 1. The inhibition of PC3 cells proliferation by GA. PC3 cells were seeded in 96-
well plates for overnight and were then treated with 0–120 mM gallic acid in DMSO
or DMSO alone for 48 h. At the end of treatment time, cell viability was measured by
MTT assay. Data indicate mean  SD, n = 3.
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and invasion in human prostate cancer PC3 cells.
2. Experimental procedures
2.1. Chemicals and antibodies
The human PC3 cell line was obtained from Pasteur Institute of
Iran (Tehran, Iran). Gallic acid, dimethyl sulfoxide (DMSO),
matrigel (ESH Sarcoma Matrigel), and 3-(4,5-dimethylthiazol-2-
yl) -2,5-diphenyltetrazolium bromide (MTT) were purchased from
sigma (St. Louis, MO, USA). RPMI 1640 medium, trypsin 0.25% and
fetal bovine serum were obtained from Gibco (Rockville, MD, USA).
SYBR Green PCR Master Mix was obtained from Qiagen Co.
(Düsseldorf, Germany). Polyvinylidene diﬂuoride (PVDF) mem-
brane and BM Blue POD Substrate Precipitating were prepared
from Roche. IL-6 ELISA kit was obtained from AviBion. BIOZOL Total
RNA Extraction kit was prepared from Bio Flux. Antibodies were
purchased from Abcam (San Francisco, CA, USA). All other
chemicals used were of analytical grade.
2.2. Cell culture and cell viability assay
PC3 cells were cultured in RPMI1640 medium enriched with L-
glutamine, 10% fetal bovine serum (FBS), 102U/ml penicillin and
0.1 mg/ml streptomycin under standard conditions (37 C, 95%
humidity and 5% CO2). The viability and proliferation of PC3 cells
were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyl-
tetrazolium bromide test (MTT assay test) [14]. Brieﬂy, PC3 cells
were seeded in 96-well plates at a density of 5000 cells/well in
RPMI 1640 medium containing 10% FBS and plates were incubated
for 24 h. The medium was replaced with medium containing
different concentrations of GA (0–120 mM) and incubated for 48 h.
Then, 100 ml of colorless RPMI 1640 and 10 ml of MTT 12 mM were
added to each well and incubated for 4 h. The medium was
removed and 50 ml of DMSO was added to each well and incubated
for 10 min in order to dissolve the formazan crystals. This test was
done in triplicate for each concentration of GA. Viability
percentage was calculated after reading absorbance of formazan
at 490 nm using a microplate reader (Stat Fax 3200, Awareness
Technology, USA) based on the following formula: Viability = A
(sample)/A (control)  100. Moreover, non-treated cell viability
was set as 100%.
2.3. Real-time polymerase chain reaction (RT-PCR) for IL-6
PC3 cells were incubated with 0, 25, 30, and 35 mM of GA for 48 h.
Then, total mRNA was extracted for each well by Biozol reagent
according to the manufacturer’s protocol. RT-PCR for IL-6 gene
expression was done using Rotor-Gene 3000 (Corbett, Australia) as
described previously [10]. The glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH), a housekeeping gene, was used as an
endogenous control gene for the normalization of IL-6 expression.
2.4. Western blot analysis
Treated PC3 cells with different concentrations of GA (0, 25, 30,
and 35 mM) were harvested after 48 h. Western blot analysis for
pSTAT3, pAKT, and pERK1/2 cellular signaling proteins were
carried out as described previously [10]. b-actin assessed as an
internal control.
2.5. Measurement of IL-6
PC3 cells were treated with various concentrations of GA (0, 25,
30, and 35 mM) in 6-well plates for 48 h. Then, their media wereDownloaded for Anonymous User (n/a) at MOH Consortium -Shahrekord
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Human IL-6 ELISA kit). All steps of this procedure were performed
according to the manufacturer’s protocols. Finally, the optical
density was measured at 450 nm using an ELISA reader (Stat Fax1
3200 Microplate Reader, Awareness Technology, USA).
2.6. Invasion assay
Transwells with 8 mm-pores, 24-well plates, and matrigel were
used for invasion assay. The upper chamber of the transwell was
coated with matrigel at a concentration of 1 mg/ml and the lower
chamber was ﬁlled with 10% FBS-medium as chemoattractan. PC3
cells were treated with different concentrations of GA (0, 25, and
35 mM) in 24 well plates for 48 h. Then, the cells were detached by
trypsin and were resuspended in 0.1% FBS-medium. PC3 cells
(5 104 per well) were added into the upper chamber of the
transwell and were incubated at 37 C in 5% CO2 for 24 h.
Subsequently, cells on the upper chamber of the transwell were
scraped with a cotton swab. Cells on the bottom side of the
transwell (migrated cells) were ﬁxed by 5% glutaraldehyde and
were stained with 0.5% toluidine blue solution. Finally, the ﬁxed
cells in the low chamber of the transwell were counted using
inverted microscope. Three independent areas per well were
counted and the mean number of migrated cells was calculated
[15].
2.7. Statistical analysis
The results were expressed as mean  SD. All statistical analysis
were performed using SPSS version 20.0 software (SPSS, Chicago,
IL, USA) and prism 5 software. Group means were compared by
Kruskal-Wallis test for multiple comparisons and P < 0.05 was
considered statistically signiﬁcant. Inhibitory concentration of 50%
(IC50) was calculated by the Probit procedure (SPSS software,
version 20). Analysis of relative gene expression data was
estimated with the DDCT method and the data were expressed
as fold change. Melting curves were generated to ensure the purity
of the ampliﬁcation product of each reaction.
3. Results
3.1. The effect of GA on PC3 cells proliferation
Fig. 1 shows the effect of GA in different concentrations range
(0–120 mM) on PC3 cells proliferation after 48 h. Results showed University from ClinicalKey.com by Elsevier on May 08, 2018.
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Fig. 3. The effect of GA on IL-6 gene expression. The expression of IL-6 was
signiﬁcantly down-regulated in PC3 cells treated with different concentrations of
GA after 48 h. Columns and bars represent mean  SD of three independent
experiments. The expression of IL-6 normalized with glyceraldehyde-3-phosphate
dehydrogenase as an internal standard.
266 E. Heidarian et al. / Biomedicine & Pharmacotherapy 84 (2016) 264–269that the survival and proliferation of PC3 cells were signiﬁcantly
decreased (P < 0.05) by increasing concentration of GA. The IC50
calculated for GA was 50 mM on PC3 cells. Also, treatment by GA
resulted in morphological changes in PC3 cells (Fig. 2).
3.2. The effect of GA on IL-6 gene expression in PC3 cells
Fig. 3 shows the effect of GA on the gene expression of IL-6 in
PC3 cells. IL-6 gene expression in treated PC3 cells with GA
signiﬁcantly down-regulated (P < 0.05) in a dose-dependent
manner. In treated PC3 cells with GA, reduction of IL-6 expression
was signiﬁcantly declined by 51.05, 85.87 and 99.72 fold at 25, 30,
and 35 mM compared to untreated cells, respectively.
3.3. Effect of GA on IL-6 protein secretion
Fig. 4 shows that treatment of PC3 cells with different
concentrations of GA resulted in a signiﬁcant reduction
(p > 0.05) in secretion of IL-6 (25.85%, 46.23% and 60.16% at 25,
30 and 35 mM of GA, respectively) when compared with control
cells.
3.4. Effects of GA on the cellular signaling pathways in PC3 cells
Fig. 5 shows the effect of GA on the cellular levels of
phosphorylated STAT3, ERK1/2, and AKT signaling proteins. GA
partially reduced the levels of pSTAT3 and pAKT at a dose of 25 mM.
On the other hand, a signiﬁcant reduction in the levels of pSTAT3
and pAKT was seen after treatment by GA at 30 and 35 mM.
Reduction in cellular level of pERK1/2 was much lower than that of
pAKT and pSTAT3 at a dose of 35 mM.Fig. 2. Morphological changes of PC3 cells after treatment with various concentr
Downloaded for Anonymous User (n/a) at MOH Consortium -Shahrek
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PC3 cells potential invasion was signiﬁcantly reduced after
treatment with GA in a dose-dependent pattern (Fig. 6). Treatment
by GA at 25 and 35 mM signiﬁcantly reduced PC3 cell invasion by
48.8% and 64.9% compared to control cells, respectively.ations of gallic acid (A: 0; B: 25; C: 30 ; and D: 35 mM, respectively) for 48 h.
ord University from ClinicalKey.com by Elsevier on May 08, 2018.
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Fig. 4. The levels of IL-6 after treatment with GA. PC3 cells were treated with
different concentrations of GA for 48 h and secreted IL-6 was measured. Data
represent the mean  SD value of three consecutive experiments.
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Nowadays, considering the side effects of chemotherapy
multiple studies have focused on the therapeutic potentials of
antioxidants and plant-derived compounds in the treatment of
diseases, especially cancer in recent years [16–18]. The prostate
cancer is known as one of the most dangerous malignant diseases
in men all over the world [1]. Our results in this study showed that
GA resulted in a reduction of cell viability and it caused changes in
morphology of PC3 cells (Figs. 1 and 2). Furthermore, GA exhibited
anti-proliferative effects on PC3 cells. These results are consistent
with previous studies [19,20]. Previous researches have demon-
strated that GA has selective toxic effects on human prostate
cancer PC3 cell line. These results suggest that tumor growthFig. 5. The effects of GA on the levels of signaling proteins in PC3 cells that were treated w
Western blot analysis. GA down-regulated the expression of pSTAT3, pAKT, and pERK1
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apoptosis in these cells as reported before [21]. Also, previous
studies have shown that GA is an anti-cancer agent with cytotoxic
effects against prostate cancer DU145 cells [21]. Previous studies
showed that antioxidants such as andrographolide can decrease
viability, survival, and metastasis in PC3 cells by inhibiting the
synthesis of IL-6 [11] which is consistent with the results of our
study. Therefore, in this study reduced IL-6 protein secretion by GA
(Fig. 4) can contribute to the reduction of viability, survival and
invasion in PC3 cells. RT-PCR has also shown a reduction in IL-6
gene expression (Fig. 3). In previous studies anti-inﬂammatory and
anti-allergic effects of GA were investigated on human basophil
cells (cell line KU812). The results suggested that GA can impose
these effects through inhibition of the expression of many
cytokines such as NF-KB and IL-6 [22]. Also, GA had inhibitory
effects on inﬂammatory mediators such as TNF-a and IL-6 in
93RS2 sertoli cells [23]. In our study, treatment with GA led to a
signiﬁcant reduction in the level of pAKT protein in PC3 cells
(Fig. 5). Previous researches have indicated that the phosphory-
lated form of AKT protein increases in many types of tumors. PI3 K/
AKT plays an important role in the progression of prostate cancer
by increasing cell proliferation and suppressing apoptosis [24,25].
On the other hand, it was found that GA has anti-metastasis effects
on gastric cancer cells through down-egulation of PI3 K/AKT
signaling protein [26]. Also, GA can induce apoptosis and inhibit
inﬂammatory cytokines such as IL-6 in ﬁbroblast-like synoviocytes
(FLS) in patients with rheumatoid arthritis [27]. Thereby, in this
study reduction of pAKT, at least in part, can be a reason for the
reduction of viability and proliferation of PC3 cells. Also, based on
our results, cellular pSTAT3 signaling protein was diminished by
GA (Fig. 5) which is in line with other studies [11]. Published
studies have shown that pSTAT3 inhibited apoptosis and resulted
in cell survival by up-regulating P53 and increasing of pro-
apoptotic factors such as Bcl-2 and Bcl-XL in cancer cells [28].
Therefore, the reduction of pSTAT3 in treated cells with GA that
was observed in our study, at least in part, led to declined cells
survival in PC3 cells. On the other hand, in our study treatmentith increasing doses of GA for 48 h. The cell lysates were collected and subjected to
/2. Equal amounts of lysate protein were subjected to gel electrophoresis.
 University from ClinicalKey.com by Elsevier on May 08, 2018.
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Fig. 6. The effect of GA on the invasion of PC3 cells. Treated PC3 cells with different
concentrations of GA for 48 h were placed in invasion chambers for 24 h at 37 C.
Invading cells were counted using inverted microscope. Bars represents the
mean  SD of triplicate determinations.
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(Fig. 5). Another study showed that GA can induce apoptosis in
HeLa cells by inactivating MAPK/ERK protein signaling pathway
[29]. Many studies have shown that MAPK/ERK pathway is
frequently activated in prostate cancer. It has been found that
IL-6 mediates growth and survival in human prostate cancer cells
by activating both MAPK/ERK and PI3K/AKT signaling pathways
[30,31]. Moreover, reduction of survival and growth in human
pulmonary ﬁbroblast (HPF) cells through reduction in MAPK
activity, was observed after treatment by GA in previous studies
[32]. Therefore, it seems that the suppression of pERK1/2 pathway
by GA in this study, at least in part, has diminished PC3 cells
survival.
In our study, GA inhibited PC3 cells invasion in a dose-
dependent manner especially in IC50 (Fig. 6) which is in agreement
with other investigators [20,33]. Previous studies have shown that
increase in pAKT activity can induce metastasis in prostate cancer
cells [24]. However, other studies have reported that GA
suppresses cell invasion in both human glioma cells and human
cervical cancer cells by inhibiting pERK1/2 and pAKT signaling
pathways [20,33] which is in line with the ﬁndings in our study.
Therefore, inhibition of pERK1/2 and pAKT pathways by GA, at least
in part, can be considered as a reason for reducing invasion of PC3
cells.
In this study, we did were not investigate the effect of GA on
proapoptotic and anti-apoptotic mediators such as p65, caspase-3,
Bcl-2, and Bax levels. These factors can play an important role in
cell proliferation, survival, apoptosis, and invasion. Therefore, we
suggest that future studies focus on the effects of GA on these
factors.
Our results show that IL-6 down-regulation and decreased IL-6
protein level in PC3 cells by GA resulted in diminished pSTAT3,
pERK, and pAKT signaling proteins which led to the reduction of
the cell survival, proliferation, and invasion in PC3 cells. Therefore,
it seems that GA can be considered an anticancer agent in the
treatment of prostate cancer.
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